Display options
Share it on

J Int Med Res. 2016 Sep;44(1):38-42. doi: 10.1177/0300060515593248.

How the immune system responds to therapeutic biological agents.

The Journal of international medical research

Alessandra Vultaggio, Giulia Petroni, Sara Pratesi, Francesca Nencini, Daniele Cammelli, Andrea Ferraro, Enrico Maggi, Andrea Matucci

Affiliations

  1. Centre of Excellence Denothe and Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  2. Department of Biomedicine, Immunoallergology Section, AOU Careggi, University of Florence, Florence, Italy.
  3. Department of Biomedicine, Immunoallergology Section, AOU Careggi, University of Florence, Florence, Italy [email protected].

PMID: 27683137 PMCID: PMC5536528 DOI: 10.1177/0300060515593248

Abstract

Biological agents target disease mechanisms and have modified the natural history of several immune-mediated disorders. Biological agents are structurally immunogenic, and therefore usually elicit a minor, subclinical and transient phenomenon. Occasionally, however, these drugs induce complete cellular and humoral immune responses, with the main clinical consequences being hypersensitivity reactions or loss of treatment response. This article considers the relative pathogenic mechanisms influencing immunogenicity in biological agents and discusses mechanisms of tolerance and adaptive immune response, including adaptive T-regulatory cell induction and immune response induction. Methods of determining cellular and humoral immune response to biological agents are identified and examined. Assays to detect antidrug antibodies and their isotypes can assist in monitoring immunogenicity and in preventing adverse events. Such strategies also enable resource conservation and may provide regulatory authorities with new insights that can be useful during the process of approving new biological or biosimilar agents.

© The Author(s) 2016.

Keywords: Adaptive response; antidrug antibodies; biologicals; humoral response; immune response; immunogenicity; tolerance

References

  1. J Rheumatol. 2004 Oct;31(10):1912-7 - PubMed
  2. Am J Gastroenterol. 2002 Dec;97(12):2962-72 - PubMed
  3. J Immunol Methods. 2011 Nov 30;374(1-2):62-9 - PubMed
  4. Allergy. 2010 May;65(5):657-61 - PubMed
  5. Can J Gastroenterol. 2000 Sep;14 Suppl C:29C-32C - PubMed
  6. J Pharm Biomed Anal. 2005 Sep 15;39(3-4):685-90 - PubMed
  7. J Rheumatol Suppl. 2010 May;85:40-52 - PubMed
  8. Clin Rev Allergy Immunol. 2010 Apr;38(2-3):82-9 - PubMed
  9. Rheumatology (Oxford). 2010 Jul;49(7):1215-28 - PubMed
  10. Aliment Pharmacol Ther. 2008 Jul;28(2):221-7 - PubMed
  11. Am J Gastroenterol. 2013 Jun;108(6):962-71 - PubMed
  12. Ann Rheum Dis. 2013 Oct;72(10):1680-6 - PubMed
  13. J Immunol Methods. 2010 Oct 31;362(1-2):82-8 - PubMed
  14. Semin Arthritis Rheum. 2005 Apr;34(5 Suppl1):19-22 - PubMed
  15. Autoimmun Rev. 2015 Aug;14(8):735-41 - PubMed
  16. J Allergy Clin Immunol. 2005 Oct;116(4):900-5 - PubMed
  17. Arthritis Rheum. 2011 Oct;63(10):2854-64 - PubMed
  18. Ann Rheum Dis. 2013 Jan;72(1):104-9 - PubMed
  19. Nephrol Dial Transplant. 2005 Jun;20 Suppl 6:vi3-9 - PubMed
  20. Transl Res. 2015 Feb;165(2):270-82 - PubMed
  21. Int Arch Allergy Immunol. 2012;159(3):321-6 - PubMed
  22. Mult Scler. 2013 May;19(6):757-64 - PubMed
  23. Blood. 2008 Oct 15;112(8):3303-11 - PubMed
  24. J Immunol. 2010 Jul 1;185(1):763-8 - PubMed
  25. Trends Pharmacol Sci. 2010 Feb;31(2):53-9 - PubMed
  26. Clin Immunol. 2013 Dec;149(3):534-55 - PubMed
  27. Clin Exp Immunol. 2015 Sep;181(3):385-400 - PubMed
  28. Drugs. 2005;65(15):2179-208 - PubMed
  29. Gut. 2012 Jul;61(7):1016-27 - PubMed

Publication Types